Published in Int J Cancer on December 21, 2012
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology (2015) 1.85
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Characteristics of gastric cancer in Asia. World J Gastroenterol (2014) 1.26
Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev (2015) 1.05
Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer (2013) 1.05
Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol (2014) 1.03
Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol (2013) 1.00
Managing the changing burden of cancer in Asia. BMC Med (2014) 0.98
Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc (2014) 0.92
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Diagnosis and management of high risk group for gastric cancer. Gut Liver (2015) 0.86
RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst (2014) 0.84
Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med (2013) 0.83
Strategies for eliminating death from gastric cancer in Japan. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.81
Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med (2015) 0.80
Helicobacter Pylori and Gastric Cancer: Clinical Aspects. Chin Med J (Engl) (2015) 0.78
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.78
Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients. J Clin Med Res (2016) 0.78
The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer. J Cancer Prev (2013) 0.77
Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies. Gastroenterol Res Pract (2016) 0.75
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLoS One (2016) 0.75
RE: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Response. J Natl Cancer Inst (2014) 0.75
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol (2016) 0.75
Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol (2015) 0.75
Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy. Biomark Res (2017) 0.75
Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep (2017) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst (2006) 3.36
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol (2008) 2.56
Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter (2010) 2.50
The long term results of endoscopic surveillance of premalignant gastric lesions. Gut (2002) 2.35
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology (2009) 2.02
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med (1999) 1.96
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter (2011) 1.82
Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A (2011) 1.81
Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol (1999) 1.73
Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy (2005) 1.60
Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol (1984) 1.41
Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol (2005) 1.40
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Liver cancer and its prevention. Asian Pac J Cancer Prev (2005) 1.13
Strategy for eliminating gastric cancer in Japan. Helicobacter (2010) 1.08
Helicobacter pylori infection and gastric cancer. Intern Med (2002) 0.94
Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers (2010) 0.89
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data. IARC Sci Publ (1996) 0.83